Correlation of the Effective Residual Vital (HPC) Dose with Engraftment Kinetics in Autologous Transplantation Amongst Myeloma and Lymphoma Patients
Sign Up to like & getrecommendations! Published in 2020 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2019.12.489
Abstract: Introduction In clinical practice, a hematopoietic progenitor cell (HPC) dose of 2 million CD34+ cells/kg is the desired minimum needed for timely neutrophil and platelet (PLT) engraftment in autologous hematopoietic cell transplantation (HCT). Patients frequently… read more here.
Keywords: lymphoma; engraftment; plt engraftment; correlation ... See more keywords